uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Lamzede
Authorised
Human
Orphan medicine
Details
EMA number
EMEA/H/C/003922
ATC code
A16AB15
Authorisation
23 March 2018
Revision
7
EMA page
Therapeutic indication
Treatment of non-neurological manifestations in patients with mild to moderate alpha-mannosidosis.
MeSH:
alpha-Mannosidosis
Group:
Other alimentary tract and metabolism products
Special characteristics
Additional monitoring
Active substances
velmanase alfa
Marketing Authorisation Holder
Chiesi Farmaceutici S.p.A.
MAH
Timeline
Filter by authority:
EMA
Lamzede authorised
23 Mar 2018
authorised
regulatory
Lamzede | uMedical